Lexicon Pharmaceuticals, Inc. (LXRX) quarterly cash flow statement — complete operating, investing & financing history
Lexicon Pharmaceuticals, Inc. (LXRX) cash flow statement — 27-year operating, investing & financing cash flows
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Cash from Operations | -23.92M | -14.73M | -17.23M | -23.83M | 16.99M | -43.78M | -21.49M | -53.62M | -48.54M | -55.13M | -50.55M | -41.62M | -38.12M | -31.61M | -21.57M | -19.44M | -24.42M | -23.42M | -22.83M | -17.15M |
| Operating CF Margin % | -3456.94% | -69.8% | -313.73% | -168.05% | 58.87% | -3468.94% | -80.93% | -3063.94% | -2947.18% | -4878.76% | -7200.57% | -25690.74% | -12024.29% | -131720.83% | -77032.14% | -49843.59% | -69777.14% | -63300% | -163057.14% | -74565.22% |
| Operating CF Growth % | -240.78% | 66.35% | 19.81% | 55.55% | 135.01% | 20.59% | 57.48% | -28.83% | -27.34% | -74.39% | -134.35% | -114.1% | -56.08% | -34.98% | 5.52% | -13.35% | -11.62% | 6.91% | 33.33% | 57.53% |
| Net Income | -32.82M | -1.04M | -15.53M | -12.77M | 3.25M | -25.3M | -33.77M | -64.81M | -53.43M | -48.4M | -49.76M | -50.52M | -44.9M | -31.93M | -30.49M | -23.39M | -24.59M | -23.48M | -25.61M | -23.12M |
| Depreciation & Amortization | 212K | 110K | 118K | 151K | 176K | 176K | 125K | 126K | 139K | 144K | 147K | 151K | 144K | 112K | 103K | 108K | 107K | 109K | 112K | 101K |
| Stock-Based Compensation | 6.41M | 3.08M | 2.83M | 3.44M | 3.19M | 3.04M | 1.54M | 2.8M | 4.86M | 4.3M | 3.21M | 3.9M | 3.81M | 3.42M | 3.27M | 2.65M | 2.83M | 2.77M | 2.23M | 2.71M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 4.17M | -462K | -108K | 3.1M | -833K | -2.46M | -1.16M | -1.43M | -4.36M | 291K | 126K | -3M | 273K | 265K | 348K | 217K | 154K | 25K | 57K | 17K |
| Working Capital Changes | -1.9M | -16.41M | -4.55M | -14.31M | 11.2M | -19.24M | 11.77M | 9.69M | 4.25M | -11.47M | -4.28M | 7.85M | 2.56M | -3.47M | 5.21M | 975K | -2.93M | -2.85M | 386K | 3.14M |
| Change in Receivables | 741K | -9.39M | -50K | -151K | 264K | 1.03M | -578K | -275K | -1.09M | -516K | -692K | 367K | -423K | -234K | 12K | -6K | 3K | -23K | 9K | 136K |
| Change in Inventory | -915K | 5K | -123K | 10K | 33K | 30K | 405K | -51K | -71K | -133K | -45K | -164K | -172K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -2M | -6.9M | -5.65M | -14M | 11.12M | -21.69M | 9.13M | 8.87M | 5.91M | -9.11M | -2.65M | 6.11M | 5.76M | -2.77M | 4.71M | 810K | -2.14M | -3.31M | -725K | 1.27M |
| Cash from Investing | -86.72M | -70.26M | 4.83M | 52.13M | 15.48M | 40.58M | 53.7M | 53.47M | -12.32M | -110.22M | 51.9M | -39.33M | -74.61M | 12.09M | 24.17M | -77.2M | -13.65M | -4.41M | 6.1M | -400K |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | -474K | -307K | -250K | 0 | 0 | -83K | -139K | -248K | -1.25M | -4K | 0 | -76K | -23K | -213K |
| CapEx % of Revenue | - | - | - | - | - | - | 1.79% | 17.54% | 15.18% | - | - | 51.23% | 43.85% | 1033.33% | 4450% | 10.26% | - | 205.41% | 164.29% | 926.09% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39.24M | 0 | 0 | -25.42M | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 440K | 0 | 1.21M | 0 | 0 | 0 | 0 | 0 | 0 | -39.24M | 0 | 0 | 25.42M | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 88.24M | 88.76M | -2.93M | 0 | -45M | -572K | -104K | -916K | -14K | 239.38M | -1K | -210K | 189M | -824K | 24.91M | 94.02M | 0 | 23.28M | -11.32M | 19.78M |
| Debt Issued (Net) | -4.26M | -5M | -3M | 0 | -45M | 0 | 0 | 0 | 0 | 0 | -1K | 1K | 49.96M | 0 | 24.97M | -249K | 0 | 24.15M | -11.7M | 0 |
| Equity Issued (Net) | 97.62M | 96.6M | 73K | -572K | 0 | -572K | -167K | -10K | -14K | 241.51M | 0 | -211K | 139.03M | -824K | -63K | 94.27M | 0 | -864K | 379K | 19.78M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | -572K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -824K | 0 | 0 | 0 | -864K | 0 | 0 |
| Other Financing | -5.12M | -2.84M | 0 | 0 | 0 | 0 | 63K | -906K | 0 | -2.13M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -22.4M | 3.76M | -15.33M | 28.29M | -12.52M | -3.77M | 32.1M | -1.07M | -60.88M | 74.03M | 1.35M | -81.16M | 76.27M | -20.34M | 27.51M | -2.62M | -38.07M | -4.54M | -28.05M | 2.23M |
| Free Cash Flow | -23.92M | -14.73M | -17.23M | -23.83M | 16.99M | -43.78M | -21.96M | -53.93M | -48.79M | -55.13M | -50.55M | -41.7M | -38.26M | -31.86M | -22.82M | -19.44M | -24.42M | -23.5M | -22.85M | -17.36M |
| FCF Margin % | -3456.94% | -69.8% | -313.73% | -168.05% | 58.87% | -3468.94% | -82.72% | -3081.49% | -2962.36% | -4878.76% | -7200.57% | -25741.98% | -12068.14% | -132754.17% | -81482.14% | -49853.85% | -69777.14% | -63505.41% | -163221.43% | -75491.3% |
| FCF Growth % | -240.78% | 66.35% | 21.54% | 55.8% | 134.83% | 20.59% | 56.55% | -29.31% | -27.54% | -73.03% | -121.56% | -114.48% | -56.65% | -35.6% | 0.16% | -11.98% | -6.99% | 6.75% | 33.37% | 57.03% |
| FCF per Share | -0.05 | -0.04 | -0.05 | -0.07 | 0.05 | -0.12 | -0.06 | -0.15 | -0.16 | -0.22 | -0.21 | -0.17 | -0.19 | -0.17 | -0.12 | -0.11 | -0.16 | -0.16 | -0.15 | -0.12 |
| FCF Conversion (FCF/Net Income) | 0.75x | 14.12x | 1.11x | 1.87x | 5.23x | 1.73x | 0.64x | 0.83x | 0.91x | 1.14x | 1.02x | 0.82x | 0.85x | 0.99x | 0.71x | 0.83x | 0.99x | 1.00x | 0.89x | 0.74x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 3.13M | 0 | 3.25M | 3.26M | 3.29M | 0 | 1.76M | 1.56M | 0 | 647K | 549K | 85K | 492K | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |